| __timestamp | HUTCHMED (China) Limited | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19764000 | 125519000 |
| Thursday, January 1, 2015 | 67426000 | 135522000 |
| Friday, January 1, 2016 | 59752000 | 137780000 |
| Sunday, January 1, 2017 | 65383000 | 162135000 |
| Monday, January 1, 2018 | 70165000 | 174885000 |
| Tuesday, January 1, 2019 | 44738000 | 174811000 |
| Wednesday, January 1, 2020 | 39457000 | 138761000 |
| Friday, January 1, 2021 | 97894000 | 187695000 |
| Saturday, January 1, 2022 | 115306000 | 581703000 |
| Sunday, January 1, 2023 | 453552000 | 709543000 |
Unlocking the unknown
In the ever-evolving landscape of the healthcare industry, Lantheus Holdings, Inc. and HUTCHMED (China) Limited have showcased intriguing financial trajectories over the past decade. From 2014 to 2023, Lantheus Holdings has consistently outperformed HUTCHMED in terms of gross profit, with a notable surge in 2023, reaching approximately 710% of its 2014 figures. This growth reflects a robust expansion strategy and effective cost management.
Conversely, HUTCHMED, while starting with a modest gross profit in 2014, has demonstrated remarkable growth, particularly in 2023, where its gross profit soared to over 2,200% of its 2014 value. This indicates a successful penetration into new markets and an increase in operational efficiency.
The data highlights the dynamic nature of the healthcare sector, where strategic decisions and market adaptability play crucial roles in financial success.
Eli Lilly and Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Pfizer Inc. and Lantheus Holdings, Inc.
Bristol-Myers Squibb Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Zoetis Inc. vs HUTCHMED (China) Limited
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Gross Profit Trends Compared: Catalent, Inc. vs Lantheus Holdings, Inc.
Jazz Pharmaceuticals plc and HUTCHMED (China) Limited: A Detailed Gross Profit Analysis
Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Lantheus Holdings, Inc. vs Perrigo Company plc
Lantheus Holdings, Inc. and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Lantheus Holdings, Inc. vs Vericel Corporation
Gross Profit Comparison: HUTCHMED (China) Limited and BioCryst Pharmaceuticals, Inc. Trends